Statistics for Xenon Pharmaceuticals Inc (id:6426 XENE)
Valuation metrics
Market cap
2.93B
Enterprise value
2.47B
Trailing P/E (ttm)
-14.07
Forward P/E
-10.78
PEG ratio
-10.78
Price/Sales (ttm)
Price/Book (mrq)
3.12
Enterprise Value/Revenue
Enterprise Value/EBITDA
-10.56
Overview
Shares outstanding
76.24M
Float
69.99M
Shares short
2.89M
% Held by insiders
5.00%
% Held by institutions
1.01%
Average volume (10 days)
361.72K
Average volume (90 days)
Price summary
52-Week low
35.53
52-Week high
50.99
52-Week change
-20.93%
Beta
1.25
50-Day moving average
41.84
200-Day moving average
40.89
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
September 30, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-18.92%
Return on equity
-26.71%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-233,680,992.00
Net income to common (ttm)
-199,060,000.00
Diluted EPS (ttm)
-2.81
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
721.53M
Total cash per share (mrq)
9.52
Total debt (mrq)
10.03M
Total Debt/Equity (mrq)
1.19
Current ratio (mrq)
2.33K%
Book value per share (mrq)
12.31
Cash flow
Cash flow statement
-153,552,000.00
Levered free cash flow (LFCF)
-104,091,504.00